rs199472795
Variant summary
The NM_000218.3(KCNQ1):c.1615C>T (p.Arg539Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene KCNQ1 is a tumor suppressor gene (CancerMine: 11 TSG, 2 oncogene citations). The gene KCNQ1 is a known oncogene (CancerMine: 11 TSG, 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.00000657 (AC=1) in the gnomAD database across 152,192 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000074019: Experimental studies have shown that this missense change affects KCNQ1 function (PMID:10728423, 15746441, 16556866, 21576493, 24681627, 25559286)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R539Q: Pathogenic/Likely_pathogenic (ClinVar VariationId 67042, 2 stars) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- long QT syndrome 1Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: G2P
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_pathogenic. The variant received 8 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O1Established oncogenic variant | TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★) | ||
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000015, AC = 1 — absent/extremely rare (O3 moderate [+2]) | ||
| O5Same location/impact as known oncogenic | Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 5 pathogenic, 0 benign (OR vs. background: 55.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.91 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KCNQ1 | MANE Select | c.1615C>T p.Arg539Trp | missense | Exon 13 of 16 | Prot: NP_000209.2 | |
KCNQ1 | c.1519C>T p.Arg507Trp | missense | Exon 12 of 15 | Prot: NP_001393765.1 | ||
KCNQ1 | c.1345C>T p.Arg449Trp | missense | Exon 14 of 17 | Prot: NP_001393766.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KCNQ1 | TSL:1MANE Select | c.1615C>T p.Arg539Trp | missense | Exon 13 of 16 | Prot: ENSP00000155840.2 UniProt: | |
KCNQ1 | TSL:1 | c.1234C>T p.Arg412Trp | missense | Exon 13 of 16 | Prot: ENSP00000334497.5 UniProt: | |
KCNQ1 | c.1612C>T p.Arg538Trp | missense | Exon 13 of 16 | Prot: ENSP00000581056.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00000657 | AC:1 | Hom:0 | AN:152192 | Cov:33 |
GnomAD2 exomes | AF: 0.00000553 | AC:1 | AN:180864 | ||
GnomAD4 exome Warning | AF: 0.00000283 | AC:4 | Hom:0 | AN:1415590 | Cov:31 |
GnomAD4 genome | AF: 0.00000657 | AC:1 | Hom:0 | AN:152192 | Cov:33 |
TOPMed (Bravo) | AF: 0.00000378 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00000481 | AC:1 | Hom:0 | AN:207788 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 26 | |
AlphaMissense | Pathogenic | 0.98 | |
BayesDel_addAF | Pathogenic | 0.51 | D |
BayesDel_noAF | Pathogenic | 0.50 | |
CADD | Pathogenic | 30 | |
CardioboostArm | Pathogenic | 1.0 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.98 | D |
Eigen | Uncertain | 0.57 | |
Eigen_PC | Uncertain | 0.47 | |
FATHMM_MKL | Uncertain | 0.83 | D |
FuncVEP CTI | Pathogenic | 0.99 | |
GPN-Star LLR | N/A | -9.6 | |
GPN-Star score | N/A | 9.6 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.93 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Uncertain | 2.5 | M |
PhyloP100 | Benign | 1.7 | |
popEVE | Benign | -3.6 | |
PrimateAI | Pathogenic | 0.83 | D |
PROVEAN | Pathogenic | -6.6 | D |
REVEL | Pathogenic | 0.94 | |
Sift | Uncertain | 0.0010 | D |
Sift4G | Uncertain | 0.0020 | D |
Varity_R | N/A | 0.75 | |
VESM-3B | Benign | -13 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.020 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.